Senseonics Investor Relations Material
Latest events
Q1 2025
Senseonics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Senseonics Holdings Inc
Access all reports
Senseonics Holdings Inc. is a medical technology company specializing in continuous glucose monitoring (CGM) systems for people with diabetes. The company’s flagship product, the Eversense CGM System, includes a long-term implantable sensor, a wearable transmitter, and a mobile app, providing real-time glucose readings and trend data. Eversense is designed to reduce the frequency of sensor replacements compared to traditional CGM systems. The company is headquartered in Germantown, Maryland, and its shares are listed on the NYSE.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
SENS
Country
🇺🇸 United States